IQVIA Holdings Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? IQVIA Holdings Inc. Common Stock trades at $258.87 (market cap $42.61B), while Relay Therapeutics Inc. Common Stock trades at $17.62 (market cap $3.82B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 11.2× Relay Therapeutics Inc. Common Stock's market cap, and IQVIA Holdings Inc. Common Stock is more actively traded (988,398 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold IQVIA Holdings Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| IQV | RLAY | |
|---|---|---|
Market Cap | $42.61B | $3.82B |
Volume | 988,398 | 4,332,079 |
Sector | Health | Health |
52-Week High | $275.02 | $20.75 |
52-Week Low | $156.66 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $56.77B | $2.93B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →